| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 196,094 shares worth roughly $15.4M.
Classified under Biotechnology (Health Care sector), IONS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 156.0K | $8.82M | - | |
| CEO | 99.9K | $5.65M | - | |
| CFO | 82.7K | $4.68M | - | |
| VP | 74.4K | $4.21M | - | |
| VP | 69.7K | $3.94M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 24,000 | $49.38 | $1,185,219.85 | -9.2% | -12.9% | -27.4% | |
| Dec 21, 2023 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 10,612 | $49.50 | $525,323.99 | -6.8% | -12.9% | -27.4% | |
| Dec 14, 2023 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 24,000 | $49.58 | $1,190,018.82 | -9.2% | -13.4% | -26.5% | |
| Dec 14, 2023 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 10,613 | $49.58 | $526,236.45 | -6.8% | -13.4% | -26.5% | |
| Dec 14, 2023 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 22,612 | $49.58 | $1,121,194.70 | -14.7% | -13.4% | -26.5% | |
| Nov 15, 2023 | Klein Joseph III60 | Director | Sell | 2,000 | $50.00 | $100,000.00 | -10.9% | -2.3% | -25.2% | |
| Oct 17, 2023 | Swayze Eric63 | EVP Research | Sale+OE | 52 | $47.95 | $2,493.35 | -41.6% | +5.2% | -19.3% | |
| Oct 12, 2023 | Monia Brett P60 | Chief Executive Officer | Sell | 3,770 | $46.00 | $173,420.00 | -3.1% | +13.3% | -16.6% | |
| Sep 28, 2023 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 4,460 | $46.50 | $207,390.00 | -6.4% | +8.4% | -11.7% | |
| Sep 26, 2023 | Parshall B Lynne74 | Director | Sell | 10,000 | $45.13 | $451,268.00 | -10.8% | +10.8% | -11.4% |